INTRODUCTION
Genitourinary menopausal syndrome (GUMS) is becoming increasingly relevant due to the increase in the general population of peri- and postmenopausal women. The role of deprivation of the urogenital tract of estrogens in the pathogenesis of the disease is obvious and has been proven long ago. There are reasons to assume the participation of oxidative stress in the implementation of GUMS.
THE PURPOSE OF THE STUDY
To identify changes in the state of lipid peroxidation (LPO) and the antioxidant defense system (AODS) in patients with menopausal genitourinary syndrome.
MATERIAL AND METHODS
We examined 40 patients aged 48—52 years (mean age was 49.2±2.7 years) with a duration of menopause for 2.5±1.3 years, 20 of whom suffered from genitourinary syndrome (group I), another 20 patients (group II) had no manifestations of this disease. All patients underwent a study of lipoperoxidation by induced serum chemiluminescence, and the amount of primary (diene conjugates) and final (Schiff bases) molecular products of lipoperoxidation in the blood.
RESULTS AND DISCUSSION
The study of LPO by biochemiluminescence showed that in patients with GUMS (group I), Imax was higher than in women without GUMS by 1.6 times, S — by 1.63 times, and tg2-by 1.75 times (p<0.05 in all cases). The study of the content of molecular products of lipid peroxidation confirmed the findings of biochemiluminometer. The level of diene conjugates in patients of group I was 2.4 times higher than in women of group II, respectively, Schiff bases were 2.2 times higher in patients with GUMS (p<0.05 in both cases). It was also found that patients with GUMS were characterized by a catalase level of 1.38 times, and SOD was 1.29 times lower (p<0.05) compared to women of group II.
CONCLUSION
The obtained data testify about the role of peroxide stress in the pathogenesis of genitourinary menopausal syndrome, which requires appropriate correction.